OHR Pharmaceutical Inc (NASDAQ:OHRP) Volume starts to pick up again. Could make a nice move to the upside. A break of $3.30 with force might give the stock room to $4.30 (200EMA). MACD and RSI indicators are also pointing North. Plus, there has been some unusual options activity (Nov $5). Keep it on your watch list.
Keep a close eye on this one tomorrow. Chardan Capital Markets analyst Gbola Amusa reiterated a Buy rating and boosted the price target on Lion Biotechnologies (NASDAQ: LBIO) to $20. The stock price is showing signs of a bounce and next level of resistance is around 7.20.
Celldex Therapeutics, Inc. (NASDAQ:CLDX) closed today's trading session at 11.96, inching up by 4.45% with the stock attracting more than 2.6 million shares. Chart shows signs of a trend reversal. Trajectories of momentum indicators on daiy charts suggest uptrend for the stock. Next major resistance lies at 12.41. February $15 calls saw some action today.